Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | TNKS | O95271 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18904981 | 1.00 | AHR (0.52) | AHRMAPTHPGDMEN1KMT2A | |
| SCHEMBL22854823 | 0.98 | AHR (0.50) | AHRMAPTHPGDMEN1KMT2A | |
| SCHEMBL20650038 | 0.98 | AHR (0.50) | AHRMAPTHPGDMEN1KMT2A | |
| SCHEMBL17944545 | 0.96 | AHR (0.49) | AHRMAPTHPGDMEN1KMT2A | |
| SCHEMBL17999986 | 0.96 | AHR (0.55) | AHRMAPTHPGDMEN1KMT2A | |
| SCHEMBL23426640 | 0.95 | MAPT (0.47) | AHRMAPTHPGDMEN1KMT2A | |
| SCHEMBL23426631 | 0.95 | MAPT (0.47) | AHRMAPTHPGDMEN1KMT2A | |
| SCHEMBL21687000 | 0.95 | AHR (0.47) | AHRMAPTHPGDMEN1KMT2A | |
| SCHEMBL23426722 | 0.95 | MAPT (0.47) | AHRMAPTHPGDMEN1KMT2A | |
| SCHEMBL23426723 | 0.95 | MAPT (0.47) | AHRMAPTHPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051250-A1 | DIAMANTANE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | TOSOH CORPORATION (JP) | 2025-02-13 | — | — | US | disclosed |
| CN-113166098-B | Triazine compound, material for organic electroluminescent element, and organic electroluminescent element | 东曹株式会社 | 2024-12-13 | — | — | CN | disclosed |
| CN-118434704-A | Bimantane compound, material for organic electroluminescent device, and organic electroluminescent device | 东曹株式会社 | 2024-08-02 | — | — | CN | disclosed |
| CN-116348454-A | Triazine compound, material for organic electroluminescent element, electron-transporting material for organic electroluminescent element, and organic electroluminescent element | 东曹株式会社 | 2023-06-27 | — | — | CN | disclosed |
| WO-2022075219-A1 | TRIAZINE COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ELECTRON TRANSPORT MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | 東ソー株式会社 | 2022-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051250-A1 | DIAMANTANE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | AOC1, ODC1, DDT | AHR 1115/4885MAPT 1001/4885HPGD 2714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.